Dr. Kevin Williams says that addressing barriers in clinical trial participation has been a big focus of the Pfizer Rare Disease unit.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.